NCT05349331 2026-01-15
WATCH
Sun Yat-sen University
Phase 2 Completed
Clinical Trials
7 trialsNCT03844750 2025-12-31
Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases
University of California, San Francisco
Phase 2 Terminated
NCT06420440 2025-05-01
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
Tongji Hospital
Phase 2 Recruiting
NCT04840186 2024-11-12
EXCALIBUR3
Oslo University Hospital
Phase 2 Suspended
NCT03801915 2023-03-21
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT05471674 2023-02-01
Neoadjuvant Anti-PD1 in HCC
The University of Hong Kong
Phase 2 Completed
NCT00153998 2009-02-27
Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)
Technische Universität Dresden
Phase 2 Completed